drugset / Trial / NCT04889651
A Study to Compare the Pharmacokinetics and Safety Between BR9004 and BR9004-1 in Healthy Male Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
To compare the pharmacokinetics and safety between BR9004 and BR9004-1 in healthy male subjects after a single-dose administration while fasting.
Timeline
- Start
- 2021-04-15
- Primary completion
- 2021-06-08
- Completion
- 2021-06-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Abiraterone acetate | Small molecule | 200 mg | Oral |
| Subject | Abiraterone acetate | Small molecule | 500 mg | Oral |